Dr. Henry Zelada Castro

Dr. Henry Zelada Castro |Clyto Access

Louis A. Weiss Memorial Hospital, USA


Expertise: Insulin Resistance


Henry Zelada has completed his MD at the age of 25 years from Universidad PeruanaCayeatno Heredia in Lima, Peru and currently is Internal Medicine Resident a Louis A Weiss Memorial Hospital, affiliated institution of University of Illinois at Chicago. He has published more than 15 abstracts in American Endocrinology conferences and more than 8 accepted research articles as the first author. He is also a reviewer for Endocrinology articles at American Journal of Epidemiology (AJE) and Global Journal of Health Science. His career aspirations include becoming a well-rounded academic endocrinologist.



Title: Updates on Type B Insulin Resistance


Type B insulin resistance (IR) is a rare autoimmune disease characterized by the presence of insulin receptor autoantibodies, resulting in a marked IR inducing hyperglycemia. Our first case is a 42-year-old female with a history of RA, SLE and Hashimoto-thyroiditis that presented with cachexia, acanthosis-nigricans, hirsutism, negative anti-insulin-ab and glucose level between 400 to 700 mg/dl, despite a total insulin dose of 1000 IU/day. She received pulses of cyclophosphamide along with prednisone. One year later the patient was off insulin and with HbA1c of 5.6%. The second case is a 42-year-old female patient that presented with polyuria, polydipsia, cachexia, acanthosis-nigricans, negative glutamic-acid-decarboxilase-ab and positive TPO-ab. She received IV infusion of regular insulin at a rate of 500 UI/d. Two years later she was off insulin with HbA1C of 5.6%. As summary, we reported a case of a disease remitted after receiving immunosuppressive therapy and a case of disease remitted spontaneously.


Related Conferences :

International Diabetes and Degenerative Diseases Conference